Diagnostic Imaging Collaboration and Licensing Deals 2016-2024

$3,995.00

Diagnostic Imaging Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024

Publication date
November 2024
Number of pages
350+
Product type
Research report
Available formats
PDF document
Report edition
5
SKU
CP21041

Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the diagnostic imaging deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of diagnostic imaging deals from 2016 to 2024.

The report provides a detailed understanding and analysis of how and why companies enter diagnostic imaging deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. 

The report includes collaboration, development, research and licensing deals.

This report contains a comprehensive listing of 645 diagnostic imaging deals announced since 2016 including financial terms where available including links to online deal records of actual diagnostic imaging partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of diagnostic imaging dealmaking. 

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in diagnostic imaging dealmaking since 2016.

Chapter 3 provides an overview of the leading diagnostic imaging deals since 2016. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in diagnostic imaging dealmaking with a brief summary followed by a comprehensive listing of diagnostic imaging deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of diagnostic imaging deals signed and announced since Jan 2016, where a contract document is available in the public domain. 

Chapter 6 provides a comprehensive and detailed review of diagnostic imaging partnering deals signed and announced since Jan 2016. The chapter is organized by specific diagnostic imaging technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in diagnostic imaging deal making since 2016.

In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Diagnostic Imaging Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2016
•    Browse diagnostic imaging collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Report scope

Diagnostic Imaging Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of diagnostic imaging trends and structure of deals entered into by leading biopharma companies worldwide.

Diagnostic Imaging Collaboration and Licensing Deals includes:
•    Trends in diagnostic imaging dealmaking in the biopharma industry
•    Directory of diagnostic imaging deal records covering pharmaceutical and biotechnology
•    The leading diagnostic imaging deals by value
•    Most active diagnostic imaging licensing dealmakers

Diagnostic Imaging Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

•    What are the precise rights granted or optioned?
•    What is actually granted by the agreement to the partner company?
•    What exclusivity is granted?
•    What is the payment structure for the deal?
•    How are sales and payments audited?
•    What is the deal term?
•    How are the key terms of the agreement defined?
•    How are IPRs handled and owned?
•    Who is responsible for commercialization?
•    Who is responsible for development, supply, and manufacture?
•    How is confidentiality and publication managed?
•    How are disputes to be resolved?
•    Under what conditions can the deal be terminated?
•    What happens when there is a change of ownership?
•    What sublicensing and subcontracting provisions have been agreed?
•    Which boilerplate clauses does the company insist upon?
•    Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
•    Which jurisdiction does the company insist upon for agreement law?

Diagnostic Imaging Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2016
•    Browse diagnostic imaging collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in diagnostic imaging dealmaking
2.1. Introduction
2.2. Diagnostic imaging deals over the years
2.3. Most active diagnostic imaging dealmakers
2.4. Diagnostic imaging deals by deal type
2.5. Diagnostic imaging deals by therapy area
2.6. Diagnostic imaging deals by industry sector
2.7. Deal terms for diagnostic imaging deals
2.7.1 Diagnostic imaging deals headline values
2.7.2 Diagnostic imaging deal upfront payments
2.7.3 Diagnostic imaging deal milestone payments
2.7.4 Diagnostic imaging royalty rates

Chapter 3 – Leading diagnostic imaging deals
3.1. Introduction
3.2. Top diagnostic imaging deals by value

Chapter 4 – Most active diagnostic imaging dealmakers
4.1. Introduction
4.2. Most active diagnostic imaging dealmakers
4.3. Most active diagnostic imaging deals company profiles

Chapter 5 – Diagnostic imaging contracts dealmaking directory
5.1. Introduction
5.2. Diagnostic imaging contracts dealmaking directory

Chapter 6 – Diagnostic imaging dealmaking by technology type

Deal directory

Deal directory – Diagnostic imaging deals by company A-Z
Deal directory – Diagnostic imaging deals by deal type
Deal directory – Diagnostic imaging deals by therapy area

Deal type definitions

About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent report titles from Current Partnering



Table of figures

Figure 1: Diagnostic imaging deals since 2016
Figure 2: Active diagnostic imaging dealmaking activity – 2016 - 2024
Figure 3: Diagnostic imaging deals by deal type since 2016
Figure 4: Diagnostic imaging deals by therapy area since 2016
Figure 5: Diagnostic imaging deals by industry sector since 2016
Figure 6: Diagnostic imaging deals with a headline value
Figure 7: Diagnostic imaging deals with an upfront value
Figure 8: Diagnostic imaging deals with a milestone value
Figure 9: Diagnostic imaging deals with a royalty rate value
Figure 10: Top diagnostic imaging deals by value since 2016
Figure 11: Most active diagnostic imaging dealmakers 2016 - 2024
Figure 12: Diagnostic imaging deals by technology type since 2016

Pricing options

  • $3,995: single-user (encrypted file - one user/device)
  • $5,995: multi-user (encrypted file - up to 5 users/devices)
  • $7,995: company (unencrypted PDF)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

3B Pharmaceuticals, 3Derm Systems, 3M, 22nd Century, Abbott Laboratories, Abbvie, Abcam, Abramson Cancer Center, ABX, ABX-CRO Advanced Pharmaceutical Services, Accudata Systems, Accuray, Acibadem University, AC Immune, ACIST Medical Systems, Acoustic MedSystems, Actelion, Acutus Medical, AdAlta, AdaptivEndo, Advanced Accelerator Applications, Advanced Chemistry Development, Advanced Human Imaging, Advanced Nuclear Medicine Ingredients, Agilent Technologies, Aidoc, Aiforia Technologies, AIG Hospitals, AI Medical Service, Akoya Biosciences, Albany Molecular Research, Albert Einstein College of Medicine, Alector, Alfasigma, Alibaba Health, Alimentiv, Allegheny Technologies, Alnylam Pharmaceuticals, Altris, Alume Biosciences, Alzheimer's Drug Discovery Foundation, Amag Pharmaceuticals, Ambergen, Ambra Health, Ambry Genetics, American College of Cardiology, American College of Chest Physicians, American Health Imaging, AMRA, AMRA Medical, Amydis, Analytics 4 Life, AnchorDx, Andor Technology, Antaros Medical, Applied Spectral Imaging, APRINOIA Therapeutics, Artialis, ARTMS Product, ARUP Laboratories, ASG Superconductors, Ashvattha Therapeutics, Asieris Pharmaceuticals, Aslan Pharma, Aspect Imaging, Aspen Imaging Healthcare, AssisTek, Astellas Pharma, AstraZeneca, Astrin Biosciences, Athinoula A Martinos Center for Biomedical Imaging, Athletic Heart Cardiac and Metabolic Testing, Austin Health, Avicenna Technology, Avinger, AVRA Surgical, Aytu BioPharma, BAMF Health, Banner Health, Baxter International, Bayer, Bay Labs, Baylor College of Medicine, BayPAT, BC Technical, Beckman Coulter, Belle.ai, Bethyl Laboratories, Biim Ultrasound, Bio-Techne, BioArctic AB, Biocare Medical, BioClinica, Biogen, BioMark Diagnostics, BiopharmX, Bioscience Pharma Partners, BioTek Instruments, BioTelemetry, Bioverativ, BioVolume, Blackford, BlackThorn Therapeutics, Blue Earth Diagnostics, Boehringer Ingelheim, BostonGene, Boston Medical Center, Boston Scientific, Bot Image, Bracco Imaging, Brain & Behavior Research Foundation, BrainLAB, Brainomix, BriaCell Therapeutics, Brigham and Women's Hospital, Broad Institute, Broncus Technologies, Bruker, Bruker Energy & Supercon Technologies (BEST), Butterfly Network, Calyx, Cambridge Research Biochemicals, Cancer Targeted Technology, Canon, Canon BioMedical, Cantel Medical, Caption Health, Cardiowise, Carestream Health, Carl Zeiss, Cartana, Case Western Reserve University, Catabasis Pharmaceuticals, CBD Solutions, Celgene, CellSight Technologies, Censis Technologies, Centre for Addiction and Mental Health, Centre for Imaging Technology Commercialization, Centre for Probe Development and Commercialization, Centre for Structural Systems Biology, CerebraCell, CereHealth, Cerevast Therapeutics, Cerveau Technologies, CgBio, Champalimaud Foundation, Champions Oncology, Check-Cap, CheckedUp, Children's Hospital Boston, China Grand Pharma, China Grand Pharmaceutical, Chinook Therapeutics, Circle cardiovascular imaging, Cirle, ClariPi, Claritas HealthTech, Clarius Mobile Health, Clarix, ClearLight Diagnostics, Clear Medical Imaging, ClearPoint Neuro, Cleveland Clinic, Client Outlook, Clinical Imaging Research Centre, Clinical Laserthermia Systems (CLS), Clovis Oncology, Cohen Veterans Bioscience, Colorado State University, Columbia University, Columbia University Medical Center, Compact Imaging, ConcertAI, Cone Health, Confo Therapeutics, Cornell University, Cortechs.ai, CorTechs Labs, Cosmo Pharmaceuticals, CrestOptics, Curasight, CureMetrix, Curium, CurveBeam AI, Cyclerion Therapeutics, CymaBay Therapeutics, D&K Engineering, Dana-Farber Cancer Institute, Data Tecnica International, Deepcell, Deep Cube, Defense Advanced Research Projects Agency, Definiens, Densitas, Dent Neurologic Institute, Department of Defense, Department of Veterans Affairs, DePuy, DiA Imaging Analysis, Diannei Biotechnology, Diaprost, Diaspective Vision, Dicom Systems, Disior, Diversigen, Draper Laboratories, DuChemBio, Duke University, Duke University Medical Center, DynamiCure Biotechnology, E.I. Medical Imaging, EchoNous, Eckert & Ziegler, Edan Instruments, Edinburgh Innovations, Edinburgh Molecular Imaging, Edwards Lifesciences, Eigen, Eisai, eKare, Eko, Elekta, Eli Lilly, Emergency Medicine Foundation, Emit Imaging, Emory University, Enable Medicine, Endoluxe, EndoSound, ENDRA Life Sciences, Enigma Biomedical, Envista, Epsilon, Erasmus University Medical Center, ERT, Essen University Hospital, Evotec, EXINI Diagnostics, Exo, Expesicor, Faes Farma, FASTVet, FEI, Ferronova, Ferrum Health, Fibrogen, FISBA, Flagship Biosciences, Florida Atlantic University Research, Fluidigm, Flywheel, Focal Healthcare, Fortis Therapeutics, Freenome, Fresenius, frog, Fujifilm Irvine Scientific, Fujifilm medical systems, FUJIFILM SonoSite, Fulcrum Therapeutics, Fuzionaire Diagnostics, Fuzionaire Radioisotope Technologies, GBI BioManufacturing, GCS Sesan, GE Healthcare, Genentech, GeneQuantum Healthcare, GenesisCare, Geneva University Hospitals, Gentex, German Cancer Research Center, Gestalt Diagnostics, GI Reviewers, Global Health Labs, Global Lung Cancer Coalition, Google, Gradient Health, Growshapes, Guardant Health, Guerbet, Guided Therapeutics, Hadassah Medical Center, Hainan Sinotau Pharmaceutical, Halo Dx, HALO Precision Diagnostics, Halt Medical, Hamamatsu Photonics, Harvard Medical School, Harvard University, Healium Medical, HealthCare Konnect, Healthmark Industries, Healthy.io, Heartflow, HeartScore, Heidelberg Pharma, Hennepin County Medical Center, Henry Ford Health System, Henry M. Jackson Foundation, Heritage Valley Health System, Hermes Medical Solutions, HistoIndex, Hitachi, Hitachi Medical Systems Europe, Holobeam Technologies, Hologic, Hospital for Special Surgery, HOYA Corporation, HP, Huami, Huma, Huvitz, Hybridyne Imaging Technologies, Hyperfine Research, IBA, Ibex Medical Analytics, IBM Watson Health, iCAD, Icagen, Icometrix, ii Ventures, Ikonopedia, ImaBiotech, Image Analysis, ImageBiopsy Lab, ImageIQ, ImaginAb, Imaging Associates, Imaging Endpoints, Imago Systems, Imanova, Imbio, Imeka, ImmersiveTouch, iMotions, Imperial College London, Imperial Innovations, Imricor Medical Systems, IMRIS, Indiana University, Indica Labs, Indivumed, Industrial Centre for Artificial Intelligence Research in Digital Diagnostics, Infervision, Infinitt, Inflazome, inHEART, InnerOptic Technology, Innodem Neurosciences, Innosuisse, Innovate BC, Inscopix, InSightec, Institut Curie, Intel, Intelligent Scopes, Intermountain Healthcare, International Association for the Study of Lung Cancer, IntroMedic, Invenio Imaging, inVentiv Health, inviCRO, Ionetix, IRIS International, iSchemaView, Isotopia Molecular Imaging, Item, Iterative Scopes, iThera Medical, ITM Isotopen Technologien, IXICO, Jain Foundation, Jana Care, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Johns Hopkins Medicine (JHM), Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Consumer Companies, Joslin Diabetes Center, Jubilant Radiopharma, Juntendo University, K2M, Kanazawa University, Kanteron Systems, Keck School of Medicine of USC, Keio Gijuku University, Kent Imaging, Kettering Health, Kheiron Medical Technologies, Kings College London, Konica Minolta, Korea Pharma, Kubota Vision, Laboratory Corporation of America, Labrador Technologies, Lantheus Holding, Lantheus Medical Imaging, Lawson Health Research Institute, Leica Microsystems, LEO Pharma, Leucid Bio, LEXEO Therapeutics, Life Image, LifeOmic, LifeTech Scientific, Lightpoint Medical, Lipidomics Consulting, Lucence, Lumicell, Lunaphore, Lung Cancer Initiative, Lunit, Luxel, M*Modal, MagCorp, Magellan Health Services, Magic Leap, Magle Chemoswed, Magnetic Insight, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Mauna Kea Technologies, Max Planck Institute for Multidisciplinary Sciences, Mayo Clinic, McGill University, MD Anderson Cancer Center, MedAxiom, Medcase, Medexus Pharmaceuticals, MEDIAN Technologies, Medical Research Council, Medidata Solutions, Medis, Mediso, Medovate, Medpace, medPhoton, MedQuest, Medtronic, MedyMatch, Meilleur Technologies, Melanoma Research Alliance, Memorial Hermann Health System, Memorial Sloan Kettering Cancer Center, Merck and Co, Merge Healthcare, Methodist Hospital Houston, Mevion Medical Systems, Michael J Fox Foundation, Michigan State University, Microsoft, MindPeak, Minerva Imaging, Mission Health, MITRO Biotech, MOBILion Systems, Molecular Instruments, MolecularMD, MolecuLight, Molnlycke Health Care, Montreal Neurological Institute-Hospital, Motus GI Medical Technologies, MRI Interventions, Munich Technical University, Myriad Genetics, Nano-X Imaging, NanoMab Technology, NASA, National Cancer Institute, National Cancer Institute of Mexico, National Center for Advancing Translational Sciences (NCATS), National Healthcare Services (NHS), National Institute of Biomedical Imaging and Bioengineering, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Institutes of Health, National Institutes of Health Clinical Center, National Physical Laboratory, National Science Foundation, National University of Ireland, Galway (NUI Galway), Naval Medical Research Center, Navidea Biopharmaceuticals, Navigate BioPharma Services, Navigate Surgical Technologies, Navignostics, NDR Medical Technology, Nektar Therapeutics, Nelson Laboratories, Neosoma, NervGen Pharma, NE Scientific, Neuro42, Neuroelectrics, NeuroLogica, NeuroNexus, NeuroScience Associates, NeuroSense Therapeutics, NeuroVision Imaging, NeuSoft Medical Technologies, Neuvogen, New England Complex Systems Institute, New York University, NexOptic, NextGate, Nihon Medi-Physics, Nikon Corporation, Nikon Instruments, Norgine, Noria Therapeutics, Northeastern University, NorthStar Medical Radioisotopes, Northwell Health, Northwestern Medicine Bluhm Cardiovascular Institute, NovAliX, Novarad, Novartis, Novo Nordisk, Novosound, NTT Data, Nuance Healthcare, Nucleo de Bioensaios Biossintese e Ecofisiologia de Produtos Naturais, Nuclidium, Numares, NuVasive, Nvidia, nView Medical, NX Development, NYU Grossman School of Medicine for Preclinical and Clinical Research, NYU Langone Medical Center, NZ Technologies, Olea Medical, Olympus, Olympus Respiratory America, OmniVision Technologies, Oncidium Foundation, One Lambda, OneMedNet, OnLume Surgical, ON Semiconductor, Onsite Women’s Health, OphtAI, Optellum, Optibrand, Optomed, Optos, OracleBio, Oregon Health Sciences University, OrthoGrid Systems, Osaka University, Oslo University Hospital, Othair Prothena, Otsuka, Otsuka America Pharmaceutical, oVio Technologies, Owkin, Owlstone Medical, Pacific Dental Services, Panacea Pharmaceuticals, Panaxium, Paracelsus Clinics, Parthenon Therapeutics, PAVmed, Pennsylvania State University, Pepscan, PerkinElmer, Pfizer, PharmaCare Management, PharmaLogic, PhenoVista Biosciences, Philips, Philochem, Phoenix Children’s Hospital, Phytronix Technologies, Ping An Ventures, Piur Imaging, Planmeca, Planmed, Plus Therapeutics, POINT Biopharma, Polarean Imaging, Positron, PreciseDx, Precision Image Analysis, Precision Optics, Premier Inc, PrinterPrezz, Profil Institute for Clinical Research, Progenics Pharmaceuticals, Promaxo, Proprio, Proscia, Provision Diagnostic Imaging, Purdue Research Foundation, Qlarity Imaging, QT Imaging, Qualigen, QuantalX Neuroscience, Quantinm, Quibim, Qure.ai, Rabin Medical Center (Beilinson Hospital), Radboud University Nijmegen Medical Centre, RadImageNet, Radiopharm Theranostics, RadNet, RapidAI, RareCyte, Ratio Therapeutics, RAW, ReadCoor, ReCor Medical, Redlen Technologies, RefleXion Medical, Remidio Innovative Solutions, Resolve Biosciences, RetinAI Medical, RetiSpec, Richardson Healthcare, Riverain Medical, Roche, Rose F Kennedy Intellectual and Developmental Disabilities Research Center, ROTOP Pharmaka, Rouumtech, Royal Philips Electronics, Salk Institute, Salud Digna, Samsung Electronics, Sana Klinikum Offenbach, Sanford Health, Sanuwave Health, Satisfai Health, Sayre Therapeutics, SciBase, Science 37, Scil Proteins, SCIMAGE, Scintomics, Scivita Medical Technology, Scopio Labs, Screenpoint Medical, SecondWave Systems, Sectra, See-Mode Technologies, Segmed, SerenaGroup, Shanghai Pharmaceutical, Shared Medical Services, Shimadzu, Siemens Healthcare, Siemens Healthineers, SimBioSys, SimonMed Imaging, Singapore Bioimaging Consortium, Sinomed, Sirtex Medical, Smilow Cancer Hospital at Yale-New Haven (SCH), Sofie Biosciences, Solis Mammography, SomaServe, SonoScape Medical, SonoThera, SOPHiA Genetics, Soricimed Biopharma, Spesana, SST Group, Standard BioTools, Stanford University, Stanford University School of Medicine, Statera Biopharma, StemoniX, Stereotaxis, Stockholm University, Storm ID, Strados Labs, Stratasys, Subtle Medical, Sumitomo Cryogenics, Sunnybrook Research Institute, Surfacide, Susan G. Komen for the Cure, Swiss Institute of Allergy and Asthma Research, Swixx Biopharma, Synaptive Medical, Synopic, SyntheticMR, Sysmex, T3 Labs, Takeda Pharmaceutical, Tau Consortium, Techcyte, Teijin, Tel Aviv University, TeleMammography Specialists, Telemedicine Solutions, Telix Pharmaceuticals, TeraRecon, The Joint Pathology Center, Theragnostics, TheraPanacea, Therapixel, Thermo Fisher Scientific, The Technical University Of Munich, Thomas Jefferson University, Tissue Analytics, Tokyo Metropolitan Institute of Gerontology, toSense, Toshiba Medical Systems Corporation, Touchstone Medical Imaging, Transcriptome Sciences, Translational Research Institute for Space Health, TransMIT, Triage Technologies, TriSalus Life Sciences, TumorGen, Turner Imaging Systems, UK Biobank, Ultivue, UltraSight, United Imaging Healthcare, University College London, University Gastroenterology, University of Arizona, University of Augsburg, University of California, San Diego, University of California, San Diego (UCSD) School of Medicine, University of California Los Angeles, University of California San Francisco, University of Glasgow, University of Heidelberg, University of Hong Kong, University of Illinois, University of Konstanz, University of Lausanne, University of Leuven, University of Louisville, University of Manchester, University of Massachusetts Medical School, University of Melbourne, University of Miami, University of Michigan, University of Michigan Medical School, University of Minnesota, University of New Mexico, University of North Carolina, University of Oxford, University of Pittsburgh, University of Queensland, University of Rennes, University of South Carolina, University of Virginia, University of Washington, University of Wisconsin-Madison, University of Wollongong, Uppsala University, UroPartners, UroViu, Us2.ai, US Air Force, USARAD, Usono, US Radiology Specialists, Vanderbilt University, Varian Medical Systems, Ventus Therapeutics, Verge Genomics, Verily, VIB, Vida Diagnostics, Vidence, Viewpoint Molecular Targeting, VIPUN Medical, Virginia Tech Intellectual Properties, Virgo Surgical Video Solutions, Visage Imaging, Visikol, VisionQuest Biomedical, Visiopharm, VisualDx, Vithas Group, Volk Optical, Volpara Solutions, VOTIS Subdermal Imaging Technologies, VU Medical Center, VUNO, WakeMed Health & Hospitals, Wallace H. Coulter Foundation, Waseda University, Washington University in St Louis, WaVe Lifesciences, Wayne State University, Weizmann Institute, WellDoc, Wellman Center For Photomedicine, Whiterabbit, Wilex, Women & Infants Hospital of Rhode Island, XLIM, XPRIZE Pandemic Alliance, Yale School of Medicine, Yale University, Yantai Dongcheng Biochemicals, Yitu Medical, York Instruments, York University, Young Blood Institute, Zebra Medical Vision, Zepp Health, Zylox Tonbridge Medical Technology Co, Ltd

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.